Sfoglia per AUTORE
GAY F
Collezione AOU Città della Salute di Torino

  

Items : 123

2025
AOU Città della Salute di Torino

Costa LJ; Gay F; Landgren O; Mateos MV; Moreau P; Touzeau C; Ertel F; McFadden I; Najdi R; Weisel K;

2025
AOU Città della Salute di Torino

Costa LJ; Gay F; Landgren O; Mateos MV; Moreau P; Touzeau C; Ertel F; McFadden I; Najdi R; Weisel K;

Blood pressure variability as predictor of cancer therapy-related cardiovascular toxicity in patients with Multiple Myeloma. in Hypertension research : official journal of the Japanese Society of Hypertension / Hypertens Res. 2025 Jan 22. doi: 10.1038/s41440-024-02084-w.
2025
ASL Città di Torino
AOU Città della Salute di Torino

Veglio F; Gay F; Bringhen S; Rabbia F; Leone D; Paladino A; Cesareo M; Colomba A; Votta S; Catarinella C; Mingrone G; Astarita A; Airale L; Fanelli E; Picca G; Milan A; Vallelonga F;

Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor. in Bone marrow transplantation / Bone Marrow Transplant. 2025 Jan;60(1):79-82. doi: 10.1038/s41409-024-02432-x. Epub 2024 Oct 4.
2025
AOU Città della Salute di Torino

Bringhen S; Santoro A; Bruno B; Lorenzi M; Francisci T; Benevolo G; De Philippis C; Mannina D; Larocca A; Taurino D; Oliva S; D'agostino M; Mariotti J; Mercadante S; Gay F; Sarina B; Casson A; Garibaldi B; Bertuglia G; Mina R; Bramanti S;

Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2025 Feb 18:JCO2401253. doi: 10.1200/JCO-24-01253.
2025
AOU Città della Salute di Torino

Kaiser MF; Sonneveld P; Cairns DA; Raab MS; San-Miguel Izquierdo J; Zhang R; Acosta J; Larocca A; Popat R; Li C; Baertsch MA; Brown SR; Lahuerta Palacios J; Gandhi AK; Macé S; Musto P; Yong K; Mai EK; Dubin F; Blade J; Capra A; Cook G; Bertsch U; Mateos MV; Boccadoro M; Jackson GH; Gutiérrez NC; Gay F; Weinhold N; et alii...

European Myeloma Network Group review and consensus statement on primary plasma cell leukemia. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2025 Apr;36(4):361-374. doi: 10.1016/j.annonc.2025.01.022. Epub 2025 Feb 7.
2025
AOU Città della Salute di Torino

Musto P; Engelhardt M; van de Donk NWCJ; Gay F; Terpos E; Einsele H; Fernández de Larrea C; Sgherza N; Bolli N; Katodritou E; Gentile M; Royer B; Derudas D; Jelinek T; Zamagni E; Rosiñol L; Paiva B; Caers J; Kaiser M; Beksac M; Hájek R; Spencer A; Ludwig H; Cavo M; Bladé J; Moreau P; Mateos MV; San-Miguel JF; Dimopoulos MA; et alii...

Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review. in Frontiers in oncology / Front Oncol. 2025 Mar 12;15:1550644. doi: 10.3389/fonc.2025.1550644. eCollection 2025.
2025
AOU Città della Salute di Torino

Gay F; Zamagni E; Cole CE; Scheid C; Hultcrantz M; Chorazy J; Iheanacho I; Pandey A; Bitetti J; Boytsov N; Purser M; McNamara S; Iida S;

Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment. in Cancers / Cancers (Basel). 2024 Sep 4;16(17):3081. doi: 10.3390/cancers16173081.
2024
AOU Città della Salute di Torino

Colomba A; Astarita A; Mingrone G; Airale L; Catarinella C; Vallelonga F; Leone D; Cesareo M; Paladino A; Bringhen S; Gay F; Pedrizzetti G; Veglio F; Milan A;

2024
AOU Città della Salute di Torino

Colomba A; Astarita A; Mingrone G; Airale L; Catarinella C; Vallelonga F; Leone D; Cesareo M; Paladino A; Bringhen S; Gay F; Pedrizzetti G; Veglio F; Milan A;

2024
AOU Città della Salute di Torino

Rodriguez-Otero P; Usmani S; Cohen AD; van de Donk NWCJ; Leleu X; Gállego Pérez-Larraya J; Manier S; Nooka AK; Mateos MV; Einsele H; Minnema M; Cavo M; Derman BA; Puig N; Gay F; Ho PJ; Chng WJ; Kastritis E; Gahrton G; Weisel K; Nagarajan C; Schjesvold F; Mikhael J; Costa L; Raje NS; Zamagni E; Hájek R; Weinhold N; Yong K; et alii...

An IL-1?-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma. in Nature immunology / Nat Immunol. 2024 May;25(5):820-833. doi: 10.1038/s41590-024-01808-x. Epub 2024 Apr 10.
2024
AOU Città della Salute di Torino

van Duin M; Bruns H; Büttner-Herold M; Moreau P; Gay F; van de Woestijne PC; Sanders MA; Tahri S; van Beek G; Hoogenboezem RM; van Heusden T; Vermeulen M; Czeti Á; Appelman MK; Papazian N; Fokkema C; de Jong MME; Broijl A; Sonneveld P; Cupedo T;

2024
AOU Alessandria
AOU Città della Salute di Torino

Bruno B; Zamagni E; Stefanoni P; Palmieri S; Liberati AM; Monaco F; Annibali O; Galieni P; Garzia M; Olivero M; Rogers J; Ruggeri M; Pescosta N; Pisani F; Tosi P; Pascarella A; Pietrantuono G; Arigoni M; De Sabbata G; Bertamini L; Belotti A; Rota-Scalabrini D; D'Agostino M; Calogero RA; Boccadoro M; Musto P; Gay F;

Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging Strategies. in American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting / Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e433520. doi: 10.1200/EDBK_433520.
2024
AOU Città della Salute di Torino

Rees MJ; D'Agostino M; Leypoldt LB; Kumar S; Weisel KC; Gay F;

Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma. in Haematologica / Haematologica. 2024 Jul 1;109(7):2337-2340. doi: 10.3324/haematol.2023.284694.
2024
AOU Città della Salute di Torino

Mateos MV; Weisel K; Terpos E; Delimpasi S; Kastritis E; Zamagni E; Delforge M; Ocio E; Katodritou E; Gay F; Larocca A; Leleu X; Otero PR; Schjesvold F; Cavo M; Dimopoulos MA;

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. in The New England journal of medicine / N Engl J Med. 2024 Jan 25;390(4):301-313. doi: 10.1056/NEJMoa2312054. Epub 2023 Dec 12.
2024
AOU Città della Salute di Torino

Moreau P; Bladé J; Rodriguez-Otero P; Carson R; de Boer CJ; Sitthi-Amorn A; Vanquickelberghe V; van Brummelen EMJ; Vieyra D; Wang J; Liu Y; Ahmadi T; Lonergan S; Jurczyszyn A; Hajek R; Spencer A; Einsele H; Vangsted A; Silzle T; Roeloffzen W; Delforge M; Rosiñol L; Sureda Balari A; Schjesvold F; Katodritou E; van de Donk NWCJ; Nijhof IS; Mina R; Gay F; et alii...

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma. in Blood / Blood. 2024 Feb 15;143(7):592-596. doi: 10.1182/blood.2023022080.
2024
AOU Città della Salute di Torino

Paris L; Zambello R; Mancuso K; Gamberi B; Palmas AD; Gozzetti A; Cellini C; Ballanti S; Velluti C; Vincelli ID; Ronconi S; Pavone V; Grasso M; Ledda A; Oliva S; Corradini P; Morè S; Belotti A; Rota-Scalabrini D; Bertuglia G; D'Agostino M; Petrucci MT; Bruno B; Musto P; Gay F;

Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry. in PloS one / PLoS One. 2024 Aug 27;19(8):e0308812. doi: 10.1371/journal.pone.0308812. eCollection 2024.
2024
AOU Città della Salute di Torino

Mollee P; McCaughan G; Gay F; Cook G; Augustson B; Huynh K; Waters N; Wellard C; Moore E; Wood EM; Fanning L; Harris A; Petrie D; Irving A; Spencer A; McQuilten ZK;

A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma. in Future oncology (London, England) / Future Oncol. 2024;20(38):3043-3063. doi: 10.1080/14796694.2024.2394323. Epub 2024 Sep 17.
2024
AOU Città della Salute di Torino

Sonneveld P; Dimopoulos MA; Boccadoro M; Quach H; Ho PJ; Beksac M; Hulin C; Antonioli E; Leleu X; Mangiacavalli S; Perrot A; Cavo M; Belotti A; Broijl A; Gay F; Mina R; van de Donk NWCJ; Katodritou E; Schjesvold F; Balari AS; Rosiñol L; Delforge M; Roeloffzen W; Silzle T; Vangsted A; Einsele H; Spencer A; Hajek R; Jurczyszyn A; et alii...

Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in Europe. in Future oncology (London, England) / Future Oncol. 2023 Oct;19(31):2103-2121. doi: 10.2217/fon-2023-0021. Epub 2023 Sep 14.
2023
AOU Città della Salute di Torino

Haefliger B; Valluri S; Erler-Yates N; Ribbands A; Luke E; Lambert A; Bailey A; Martínez-Lopez J; Gay F;

Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study. in The Lancet. Oncology / Lancet Oncol. 2023 Oct;24(10):1119-1133. doi: 10.1016/S1470-2045(23)00405-9. Epub 2023 Sep 14.
2023
AOU Città della Salute di Torino

Benjamin R; Hájek R; Zweegman S; Silkjaer T; Caers J; Mancuso K; Tacchetti P; Razawy W; Grasso M; Giaccone L; Offidani M; Lund T; van der Velden VHJ; Pour L; Gadisseur A; Pietrantuono G; Broijl A; Roeloffzen WWH; Wu KL; Schjesvold F; van der Holt B; Minnema MC; van de Donk NWCJ; Vangsted AJ; Boccadoro M; Gay F; Sonneveld P; Musto P;

2023
AOU Città della Salute di Torino

Ludwig H; Terpos E; van de Donk N; Mateos MV; Moreau P; Dimopoulos MA; Delforge M; Rodriguez-Otero P; San-Miguel J; Yong K; Gay F; Einsele H; Mina R; Caers J; Driessen C; Musto P; Zweegman S; Engelhardt M; Cook G; Weisel K; Broijl A; Beksac M; Bila J; Schjesvold F; Cavo M; Hajek R; Touzeau C; Boccadoro M; Sonneveld P; et alii...

Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). in Leukemia / Leukemia. 2023 Jun;37(6):1175-1185. doi: 10.1038/s41375-023-01920-1. Epub 2023 May 4.
2023
AOU Città della Salute di Torino

Terpos E; Musto P; Engelhardt M; Delforge M; Cook G; Gay F; van de Donk NWCJ; Ntanasis-Stathopoulos I; Vangsted AJ; Driessen C; Schjesvold F; Cerchione C; Zweegman S; Hajek R; Moreau P; Einsele H; San-Miguel J; Boccadoro M; Dimopoulos MA; Sonneveld P; Ludwig H;

Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing. in EClinicalMedicine / EClinicalMedicine. 2023 Jun 9;60:102016. doi: 10.1016/j.eclinm.2023.102016. eCollection 2023 Jun.
2023
AOU Città della Salute di Torino

Oliva S; Genuardi E; Paris L; D'Agostino M; Rogers J; Rota-Scalabrini D; Jacob AP; Patriarca F; Luppi M; Bertazzoni P; Velluti C; Capra A; Saraci E; Rossi M; Allegra A; Mina R; Gentile M; Kirsch IR; Belotti A; Cavo M; Bruno B; Musto P; Boccadoro M; Zamagni E; Gay F;

2023
AOU Città della Salute di Torino

Zamagni E; Oliva S; Gay F; Capra A; Rota-Scalabrini D; D'Agostino M; Belotti A; Galli M; Racca M; Zambello R; Gamberi B; Albano D; Bertamini L; Versari A; Grasso M; Sgherza N; Priola C; Fioritoni F; Patriarca F; De Cicco G; Villanova T; Pascarella A; Zucchetta P; Tacchetti P; Fanti S; Mancuso K; Barbato S; Boccadoro M; Musto P; et alii...

2023
AOU Città della Salute di Torino

Grasso M; Zamagni E; Fioritoni F; Ballanti S; Cea M; Pescosta N; Pavone V; Ronconi S; Vincelli ID; Oddolo D; Capra A; Bertamini L; Cellini C; Gozzetti A; De Rosa L; Giuliani N; Aquino S; de Fabritiis P; Gamberi B; Palmas A; Rota-Scalabrini D; Paris L; Musto P; Mina R; Belotti A; Boccadoro M; Gay F;

2023
AOU Città della Salute di Torino

Astarita A; Mingrone G; Airale L; Cesareo M; Colomba A; Catarinella C; Leone D; Gay F; Bringhen S; Veglio F; Milan A; Vallelonga F;

2023
AOU Città della Salute di Torino

Mingrone G; Astarita A; Colomba A; Catarinella C; Cesareo M; Airale L; Paladino A; Leone D; Vallelonga F; Bringhen S; Gay F; Veglio F; Milan A;

A rational approach to functional high-risk myeloma. in Hematology. American Society of Hematology. Education Program / Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):433-442. doi: 10.1182/hematology.20230004
2023
AOU Città della Salute di Torino

Gay F; Bertuglia G; Mina R;

Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma. in Experimental hematology & oncology / Exp Hematol Oncol. 2023 Aug 10;12(1):71. doi: 10.1186/s40164-023-00434-x.
2023
AOU Città della Salute di Torino

Bandini C; Mereu E; Paradzik T; Labrador M; Maccagno M; Cumerlato M; Oreglia F; Prever L; Manicardi V; Taiana E; Ronchetti D; D'Agostino M; Gay F; Larocca A; Besse L; Merlo GR; Hirsch E; Ciarrocchi A; Inghirami G; Neri A; Piva R;

2023
AOU Città della Salute di Torino

Raje N; Anderson K; Einsele H; Efebera Y; Gay F; Hammond SP; Lesokhin AM; Lonial S; Ludwig H; Moreau P; Patel K; Ramasamy K; Mateos MV;

Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Sep 20;40(27):3132-3150. doi: 10.1200/JCO.21.01217. Epub 2022 Mar 31.
2022
AOU Città della Salute di Torino

Moreau P; Musto P; Munshi NC; Avet-Loiseau H; Gay F; Broijl A; Vermeulen M; Valent ET; Beverloo HB; van der Holt B; Hoogenboezem R; van der Velden VHJ; Cupedo T; van Duin M; Kuiper R; Hofste Op Bruinink D; Zweegman S; van de Donk NWCJ; Sonneveld P;

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Sep 20;40(27):3120-3131. doi: 10.1200/JCO.21.01393. Epub 2022 Jun 6.
2022
AOU Alessandria
AOU Città della Salute di Torino

Musto P; Boccadoro M; Gay F; Belotti A; Tacchetti P; Fazio F; Zambello R; Luppi M; Liberati AM; Palmieri S; Annibali O; Monaco F; Galieni P; Pisani F; Capra A; Gilestro M; Curci P; Pascarella A; Tosi P; De Sabbata G; Pietrantuono G; Gentile M; Ledda A; Paris L; Morè S; Corradini P; Rota-Scalabrini D; Oliva S; Bertamini L; et alii...

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Oct 10;40(29):3406-3418. doi: 10.1200/JCO.21.02614. Epub 2022 May 23.
2022
AOU Città della Salute di Torino

Cook G; Larocca A; Hernández Rivas JM; Goldschmidt H; Kaiser MF; Cavo M; Zweegman S; Gay F; Dürig J; Mai EK; Capra A; Castellani G; Bonello F; van der Holt B; Salwender H; Bladé Creixenti J; Rocchi S; van de Donk NWCJ; Jackson G; Dall'Olio D; Mateos MV; Zamagni E; Waage A; Bertsch U; Lahuerta JJ; Wester R; Cairns DA; D'Agostino M; San-Miguel JF; et alii...

ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Jun;28(6):284-293. doi: 10.1016/j.jtct.2022.03.019. Epub 2022 Mar 17.
2022
AOU Città della Salute di Torino

Silberman R; Iftikhar R; Abonour R; Moreau P; Otero PR; Malhotra P; Biran N; Callander N; Janakiram M; Mohty M; Prince M; Beksac M; Chaudhry M; Aljurf M; Costa L; Hou J; Schriber J; Quach H; Einsele H; Cook G; Gay F; Costello C; Poudyal BS; Cowan A; Garfall A; Lonial S; Kumar A; Shah N; Kansagra A; et alii...

The EHA Research Roadmap: Malignant Lymphoid Diseases. in HemaSphere / Hemasphere. 2022 May 19;6(6):e726. doi: 10.1097/HS9.0000000000000726. eCollection 2022 Jun.
2022
AOU Città della Salute di Torino

Dreyling M; André M; Gökbuget N; Tilly H; Jerkeman M; Gribben J; Ferreri A; Morel P; Stilgenbauer S; Fox C; Maria Ribera J; Zweegman S; Aurer I; Bödör C; Burkhardt B; Buske C; Dollores Caballero M; Campo E; Chapuy B; Davies A; de Leval L; Doorduijn J; Federico M; Gaulard P; Gay F; Ghia P; Grønbæk K; Goldschmidt H; Kersten MJ; et alii...

Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma? in International journal of molecular sciences / Int J Mol Sci. 2022 Dec 14;23(24):15879. doi: 10.3390/ijms232415879.
2022
AOU Città della Salute di Torino

Bertuglia G; Cani L; Larocca A; Gay F; D'Agostino M;

Melflufen for the treatment of multiple myeloma. in Expert review of clinical pharmacology / Expert Rev Clin Pharmacol. 2022 Apr;15(4):371-382. doi: 10.1080/17512433.2022.2075847. Epub 2022 Jun
2022
AOU Città della Salute di Torino

Ocio EM; Nadeem O; Schjesvold F; Gay F; Touzeau C; Dimopoulos MA; Richardson PG; Mateos MV;

Multiple myeloma with t(11;14): unique biology and evolving landscape. in American journal of cancer research / Am J Cancer Res. 2022 Jul 15;12(7):2950-2965. eCollection 2022.
2022
AOU Città della Salute di Torino

Costa LJ; Dogan A; Hungria VT; Gay F; Fonseca R; Kumar SK; Bal S;

2021
AOU Città della Salute di Torino

Einsele H; Palumbo A; Straka C; Corradini P; Wäsch R; Gentili S; Schub N; Spada S; Pönisch W; Aquino S; Patriarca F; Montefusco V; Salvini M; Engelhardt M; Offidani M; Günther A; Gay F; Boccadoro M; Sonneveld P; Gramatzki M;

Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2021 Oct 1;27(19):5195-5212. doi: 10.1158/1078-0432.CCR-21-1059.
2021
AOU Città della Salute di Torino

Anderson KC; Auclair D; Adam SJ; Agarwal A; Anderson M; Avet-Loiseau H; Bustoros M; Chapman J; Connors DE; Dash A; Di Bacco A; Du L; Facon T; Flores-Montero J; Gay F; Ghobrial IM; Gormley NJ; Gupta I; Higley H; Hillengass J; Kanapuru B; Kazandjian D; Kelloff GJ; Kirsch IR; Kremer B; Landgren O; Lightbody E; Lomas OC; Lonial S; et alii...

The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma. in Transplantation and cellular therapy / Transplant Cell Ther. 2021 Oct;27(10):807-816. doi: 10.1016/j.jtct.2021.05.027. Epub 2021 Jun 6.
2021
AOU Città della Salute di Torino

Paiva B; Dwyer MO; Merz M; Melenhorst JJ; Maus MV; Kaiser M; Hillengass J; Gormley N; Ghobrial IM; Gay F; Foureau D; Brownstein C; Demolis P; Bhutani M; Bolli N; Bergsagel PL; Bahlis N; Holstein SA; Pasquini MC; Shah N; Wong SW; Usmani SZ; McCarthy PL;

Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Nov 10;39(32):3613-3622. doi: 10.1200/JCO.21.01045. Epub 2021 Sep 14.
2021
AOU Città della Salute di Torino

Sonneveld P; Dimopoulos MA; Beksac M; van der Holt B; Aquino S; Ludwig H; Zweegman S; Zander T; Zamagni E; Wester R; Hajek R; Pantani L; Dozza L; Gay F; Cafro A; De Rosa L; Morelli A; Gregersen H; Gulbrandsen N; Cornelisse P; Troia R; Oliva S; van de Velden V; Wu K; Ypma PF; Bos G; Levin MD; Pour L; Driessen C; et alii...

The role of autologous stem-cell transplantation in multiple myeloma in 2021. in Current opinion in oncology / Curr Opin Oncol. 2021 Nov 1;33(6):642-647. doi: 10.1097/CCO.0000000000000783.
2021
AOU Città della Salute di Torino

Mina R; Gay F;

2021
AOU Città della Salute di Torino

Engelhardt M; Musto P; Caers J; Bolli N; Kaiser M; Van de Donk N; Terpos E; Broijl A; De Larrea CF; Gay F; Goldschmidt H; Hajek R; Vangsted AJ; Zamagni E; Zweegman S; Cavo M; Dimopoulos M; Einsele H; Ludwig H; Barosi G; Boccadoro M; Mateos MV; Sonneveld P; Miguel JS;

Antibody-drug conjugates: when chemotherapy meets immuno-oncology. in The Lancet. Haematology / Lancet Haematol. 2021 Nov;8(11):e778-e779. doi: 10.1016/S2352-3026(21)00236-2. Epub 2021 Sep 13.
2021
AOU Città della Salute di Torino

Mina R; Gay F;

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. in The Lancet. Oncology / Lancet Oncol. 2021 Mar;22(3):e105-e118. doi: 10.1016/S1470-2045(20)30756-7.
2021
AOU Città della Salute di Torino

Moreau P; Kumar SK; San Miguel J; Davies F; Zamagni E; Bahlis N; Ludwig H; Mikhael J; Terpos E; Schjesvold F; Martin T; Yong K; Durie BGM; Facon T; Jurczyszyn A; Sidana S; Raje N; van de Donk N; Lonial S; Cavo M; Kristinsson SY; Lentzsch S; Hajek R; Anderson KC; João C; Einsele H; Sonneveld P; Engelhardt M; Fonseca R; et alii...

When and How to Treat Relapsed Multiple Myeloma. in American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting / Am Soc Clin Oncol Educ Book. 2021 Mar;41:358-375. doi: 10.1200/EDBK_320129.
2021
AOU Città della Salute di Torino

Nathwani N; Bertamini L; Banerjee R; Gay F; Shah N; Krishnan A;

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial. in Blood cancer journal / Blood Cancer J. 2021 Jun 3;11(6):106. doi: 10.1038/s41408-021-00498-0.
2021
AOU Città della Salute di Torino

Oliva S; Bruinink DHO; Rihova L; D'Agostino M; Pantani L; Capra A; van der Holt B; Troia R; Petrucci MT; Villanova T; Vsianska P; Jugooa R; Brandt-Hagens C; Gilestro M; Offidani M; Ribolla R; Galli M; Hajek R; Gay F; Cavo M; Omedé P; van der Velden VHJ; Boccadoro M; Sonneveld P;

Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR. in Leukemia / Leukemia. 2021 Jun;35(6):1732-1744. doi: 10.1038/s41375-020-01049-5. Epub 2020 Oct 16.
2021
AOU Città della Salute di Torino

Szabo Z; Desgraz R; Cook G; Delforge M; Gay F; Mateos MV; Weisel K; DeCosta L; Moreau P;

Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2021 Jul 1;27(13):3695-3703. doi: 10.1158/1078-0432.CCR-21-0134. Epub 2021 Apr 29.
2021
AOU Città della Salute di Torino

Hájek R; Spencer A; Nagler A; Gaidano G; Belotti A; Benevolo G; Patriarca F; Mina R; Ruggeri M; Cascavilla N; de Fabritiis P; Mannina D; Liberati AM; Romano A; Capra A; Corradini P; Offidani M; Petrucci MT; Bertamini L; Zaccaria GM; Sonneveld P; Musto P; Boccadoro M; Gay F;

Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):e21-e24. doi: 10.1016/j.clml.2020.08.019. Epub 2020 Sep 1
2021
AOU Città della Salute di Torino

Zamagni E; Boccadoro M; Gay F; Bonello F; Mina R;

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. in Leukemia / Leukemia. 2021 Jan;35(1):31-44. doi: 10.1038/s41375-020-01016-0. Epub 2020 Aug 19.
2021
AOU Città della Salute di Torino

van de Donk N; Leleu X; Engelhardt M; Garderet L; Jackson G; Weisel K; Caers J; Delforge M; Mateos MV; Einsele H; Mohty M; Zojer N; Terpos E; Avet-Loiseau H; Gay F; Dimopoulos MA; Hajek R; Facon T; Driessen C; Zweegman S; Pawlyn C; San-Miguel J; Cavo M; Moreau P; Boccadoro M; Ludwig H; Goldschmidt H; Beksac M; Nijhof I; et alii...

2021
AO Cuneo
AOU Città della Salute di Torino

Petrucci MT; Gamberi B; Zambello R; Palmas A; de Fabritiis P; Aquino S; Giuliani N; Capra A; D'Agostino M; Patriarca F; Spadano A; Cea M; Ballanti S; Ledda A; Grasso M; Zamagni E; Offidani M; Galli M; Belotti A; Bertamini L; Rota-Scalabrini D; Musto P; Gay F; Corradini P; Cavo M; Boccadoro M;

COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. in The Lancet. Haematology / Lancet Haematol. 2021 Dec;8(12):e934-e946. doi: 10.1016/S2352-3026(21)00278-7. Epub 2021 Oct 28.
2021
AOU Città della Salute di Torino

Ludwig H; Sonneveld P; Facon T; San-Miguel J; Avet-Loiseau H; Mohty M; Mateos MV; Moreau P; Cavo M; Pawlyn C; Zweegman S; Engelhardt M; Driessen C; Cook G; Dimopoulos MA; Gay F; Einsele H; Delforge M; Caers J; Weisel K; Jackson G; Garderet L; van de Donk N; Leleu X; Goldschmidt H; Beksac M; Nijhof I; Schreder M; Abildgaard N; et alii...

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma. in Haematologica / Haematologica. 2021 Aug 1;106(8):2054-2065. doi: 10.3324/haematol.2020.276402.
2021
AOU Città della Salute di Torino

Bruno B; Wäsch R; Engelhardt M; Gay F; Giaccone L; D'Agostino M; Rodríguez-Lobato LG; Danhof S; Gagelmann N; Kröger N; Popat R; Van de Donk NWCJ; Terpos E; Dimopoulos MA; Sonneveld P; Einsele H; Boccadoro M;

Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved? in Leukemia research / Leuk Res. 2021 Aug;107:106592. doi: 10.1016/j.leukres.2021.106592. Epub 2021 Apr 24.
2021
AOU Città della Salute di Torino

Boccadoro M; Gay F; Oliva S; Bonello F; Ferrero D;

Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. in British journal of haematology / Br J Haematol. 2021 Aug;194(3):496-507. doi: 10.1111/bjh.17338. Epub 2021 Mar 16.
2021
AOU Città della Salute di Torino

Sezer O; Sonneveld P; Reece D; Rasche L; Moreau P; Mohty M; Merlini G; Lentzsch S; Mateos MV; Leleu X; Leal da Costa F; Kyle RA; Kröger N; Jurczyszyn A; Hungria V; Hájek R; Gay F; Gahrton G; Fernández de Larrea C; Engelhardt M; Dispenzieri A; Einsele H; Dimopoulos MA; Cavo M; Caers J; Badros A; Anderson KC; Van de Donk NWCJ; Zamagni E; et alii...

2021
AOU Città della Salute di Torino

Astarita A; Mingrone G; Airale L; Vallelonga F; Covella M; Catarinella C; Cesareo M; Bruno G; Leone D; Giordana C; Cetani G; Salvini M; Gay F; Bringhen S; Rabbia F; Veglio F; Milan A;

MRD Assessment in Multiple Myeloma: Progress and Challenges. in Current hematologic malignancy reports / Curr Hematol Malig Rep. 2021 Apr;16(2):162-171. doi: 10.1007/s11899-021-00633-5. Epub 2021 May 5.
2021
AOU Città della Salute di Torino

Bertamini L; D'Agostino M; Gay F;

Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients. in Frontiers in cardiovascular medicine / Front Cardiovasc Med. 2021 Apr 21;8:645678. doi: 10.3389/fcvm.2021.645678. eCollection 2021.
2021
AOU Città della Salute di Torino

Veglio F; Bringhen S; Gay F; Cetani G; Salvini M; Catarinella C; Avenatti E; Leone D; Bruno G; Crea T; Cesareo M; Maffei I; Airale L; Astarita A; Mingrone G; Vallelonga F; Milan A;

Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma. in Journal of clinical medicine / J Clin Med. 2020 Sep 27;9(10):3120. doi: 10.3390/jcm9103120.
2020
AOU Città della Salute di Torino

Mateos MV; Bladé J; Bringhen S; Ocio EM; Efebera Y; Pour L; Gay F; Sonneveld P; Gullbo J; Richardson PG;

Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2020 Sep 15;26(18):4832-4841. doi: 10.1158/1078-0432.CCR-20-0951. Epub 2020 Jul 2.
2020
AOU Città della Salute di Torino

D'Agostino M; Zaccaria GM; Ziccheddu B; Rustad EH; Genuardi E; Capra A; Oliva S; Auclair D; Yesil J; Colucci P; Keats JJ; Gambella M; Bringhen S; Larocca A; Boccadoro M; Bolli N; Maura F; Gay F; D'Agostino M; Zaccaria GM; Ziccheddu B; Rustad EH; Genuardi E; Capra A; Oliva S; Auclair D; Yesil J; Colucci P; Keats JJ; et alii...

Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2020 Oct;26(10):e247-e255. doi: 10.1016/j.bbmt.2020.06.011. Epub 2020
2020
AOU Città della Salute di Torino

Holstein SA; Howard A; Avigan D; Bhutani M; Cohen AD; Costa LJ; Dhodapkar MV; Gay F; Gormley N; Green DJ; Hillengass J; Korde N; Li Z; Mailankody S; Neri P; Parekh S; Pasquini MC; Puig N; Roodman GD; Samur MK; Shah N; Shah UA; Shi Q; Spencer A; Suman VJ; Usmani SZ; McCarthy PL; Holstein SA; Howard A; et alii...

Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen? in The Lancet. Haematology / Lancet Haematol. 2020 May;7(5):e355-e357. doi: 10.1016/S2352-3026(19)30254-6. Epub 2020 Mar 11.
2020
AOU Città della Salute di Torino

Gay F; Mina R; D'Agostino M;

Checkpoint inhibitors and myeloma: promises, deadlocks and new directions. in Annals of translational medicine / Ann Transl Med. 2020 Jun;8(12):777. doi: 10.21037/atm.2020.02.65.
2020
AOU Città della Salute di Torino

Bertamini L; Gay F;

2020
AOU Città della Salute di Torino

Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; et alii...

Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs. in Haematologica / Haematologica. 2020 Jan;105(1):193-200. doi: 10.3324/haematol.2019.219139. Epub 2019 Jun 20.
2020
AOU Città della Salute di Torino

Cavo M; Liberati AM; Sonneveld P; Offidani M; Hajek R; Ben-Yehuda D; Nagler A; Cascavilla N; Nozzoli C; Ballanti S; Galieni P; Patriarca F; Musto P; Musolino C; Ribolla R; Di Raimondo F; De Paoli L; Spada S; Gay F; Montefusco V; Corradini P; Boccadoro M;

2020
AOU Città della Salute di Torino

Chari A; Samur MK; Martinez-Lopez J; Cook G; Biran N; Yong K; Hungria V; Engelhardt M; Gay F; García Feria A; Oliva S; Oostvogels R; Gozzetti A; Rosenbaum C; Kumar S; Stadtmauer EA; Einsele H; Beksac M; Weisel K; Anderson KC; Mateos MV; Moreau P; San-Miguel J; Munshi NC; Avet-Loiseau H;

Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). in Leukemia / Leukemia. 2020 Aug;34(8):2000-2011. doi: 10.1038/s41375-020-0876-z. Epub 2020 May 22.
2020
AOU Città della Salute di Torino

Terpos E; Engelhardt M; Cook G; Gay F; Mateos MV; Ntanasis-Stathopoulos I; van de Donk NWCJ; Avet-Loiseau H; Hajek R; Vangsted AJ; Ludwig H; Zweegman S; Moreau P; Einsele H; Boccadoro M; San Miguel J; Dimopoulos MA; Sonneveld P; Terpos E; Engelhardt M; Cook G; Gay F; Mateos MV; Ntanasis-Stathopoulos I; van de Donk NWCJ; Avet-Loiseau H; Hajek R; Vangsted AJ; Ludwig H; et alii...

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents. in Blood cancer journal / Blood Cancer J. 2020 Apr 14;10(4):40. doi: 10.1038/s41408-020-0307-4.
2020
AOU Città della Salute di Torino

Mina R; Joseph NS; Gay F; Kastritis E; Petrucci MT; Kaufman JL; Montefusco V; Gavriatopoulou M; Patriarca F; Omedé P; Boise LH; Roussou M; Giuliani N; Oliva S; Offidani M; Belotti A; Jaye DL; De Paoli L; Terpos E; Lonial S; Boccadoro M; Nooka AK; Dimopoulos MA;

Editorial: Exploiting the Immune System to Treat Multiple Myeloma: From Transplantation to Novel Treatment Approaches. in Frontiers in oncology / Front Oncol. 2020 Oct 6;10:607571. doi: 10.3389/fonc.2020.607571. eCollection 2020.
2020
AOU Città della Salute di Torino

Gay F; Kastritis E; van de Donk NWCJ;

Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case Report. in Acta haematologica / Acta Haematol. 2020;143(5):481-485. doi: 10.1159/000502538. Epub 2019 Sep 25.
2020
AOU Città della Salute di Torino

Fizzotti M; Aglietta M; Becco P; Bonzano A; Lombardi P; Marandino L; Ghisoni E; Gay F; Rota Scalabrini D;

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis. in Cancers / Cancers (Basel). 2019 Nov 5;11(11):1735. doi: 10.3390/cancers11111735.
2019
AOU Città della Salute di Torino

Bonello F; Pulini S; Ballanti S; Gentile M; Spada S; Annibali O; Omedé P; Ronconi S; Cangialosi C; Podda L; Palmas A; Malfitano A; Rivoli G; Belotti A; Ciambelli F; Vincelli ID; Cafro AM; Innao V; Palumbo A; Sonneveld P; Spencer A; Hájek R; Boccadoro M; Gay F;

2019
AOU Città della Salute di Torino

Bruno G; Bringhen S; Maffei I; Iannaccone A; Crea T; Ravera A; Astarita A; Vallelonga F; Salvini M; Gay F; Veglio F; Milan A;

Do we need cytogenetics in the follow-up of multiple myeloma? in British journal of haematology / Br J Haematol. 2019 May;185(3):399-401. doi: 10.1111/bjh.15781. Epub 2019 Feb 1.
2019
AOU Città della Salute di Torino

Gay F; Goldschmidt H;

Redefining the treatment paradigm for multiple myeloma. in The Lancet. Oncology / Lancet Oncol. 2019 Jun;20(6):743-744. doi: 10.1016/S1470-2045(19)30295-5. Epub 2019 May 13.
2019
AOU Città della Salute di Torino

Gay F; Mina R;

2019
AOU Città della Salute di Torino

Boccadoro M; Dimopoulos MA; Caers J; Gramatzki M; Auner HW; Ludwig H; Driessen C; Cavo M; Goldschmidt H; Terpos E; Zweegman S; Offidani M; Larocca A; Gay F; Wäsch R; Ferri C; D'Agostino M; Milan A; Bringhen S; Einsele H; Sonneveld P; Engelhardt M;

Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma. in Cancers / Cancers (Basel). 2019 Dec 19;12(1):15. doi: 10.3390/cancers12010015.
2019
AOU Città della Salute di Torino

Bonello F; Mina R; Boccadoro M; Gay F;

Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies. in Cancers / Cancers (Basel). 2019 Dec 13;11(12):2015. doi: 10.3390/cancers11122015.
2019
AOU Città della Salute di Torino

D'Agostino M; Bertamini L; Oliva S; Boccadoro M; Gay F;

Moving Toward Continuous Therapy in Multiple Myeloma. in Clinical hematology international / Clin Hematol Int. 2019 Nov 12;1(4):189-200. doi: 10.2991/chi.d.191101.001. eCollection 2019 Dec.
2019
AOU Città della Salute di Torino

Bonello F; Cetani G; Bertamini L; Gay F; Larocca A;

CyTOF®: A New Tool to Decipher the Immunomodulatory Activity of Daratumumab. in Cytometry. Part A : the journal of the International Society for Analytical Cytology / Cytometry A. 2019 Apr;95(4):416-418. doi: 10.1002/cyto.a.23752. Epub 2019 Mar 25.
2019
AOU Città della Salute di Torino

Castella B; Mina R; Gay F;

Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma. in Current medicinal chemistry / Curr Med Chem. 2019;26(32):5968-5981. doi: 10.2174/0929867325666180514114806.
2019
AOU Città della Salute di Torino

D'Agostino M; Gazzera G; Cetani G; Bringhen S; Boccadoro M; Gay F;

2018
AOU Città della Salute di Torino

Bringhen S; Milan A; Ferri C; Wäsch R; Gay F; Larocca A; Salvini M; Terpos E; Goldschmidt H; Cavo M; Petrucci MT; Ludwig H; Auner HW; Caers J; Gramatzki M; Boccadoro M; Einsele H; Sonneveld P; Engelhardt M; Bringhen S; Milan A; Ferri C; Wäsch R; Gay F; Larocca A; Salvini M; Terpos E; Goldschmidt H; Cavo M; et alii...

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis. in JAMA oncology / JAMA Oncol. 2018 Oct 1;4(10):1389-1397. doi: 10.1001/jamaoncol.2018.2961.
2018
AOU Città della Salute di Torino

Gay F; Jackson G; Rosiñol L; Holstein SA; Moreau P; Spada S; Davies F; Lahuerta JJ; Leleu X; Bringhen S; Evangelista A; Hulin C; Panzani U; Cairns DA; Di Raimondo F; Macro M; Liberati AM; Pawlyn C; Offidani M; Spencer A; Hájek R; Terpos E; Morgan GJ; Bladé J; Sonneveld P; San-Miguel J; McCarthy PL; Ludwig H; Boccadoro M; et alii...

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. in Haematologica / Haematologica. 2018 Nov;103(11):1772-1784. doi: 10.3324/haematol.2018.189159. Epub 2018 Aug 31.
2018
AOU Città della Salute di Torino

Caers J; Garderet L; Kortüm KM; O'Dwyer ME; van de Donk NWCJ; Binder M; Dold SM; Gay F; Corre J; Beguin Y; Ludwig H; Larocca A; Driessen C; Dimopoulos MA; Boccadoro M; Gramatzki M; Zweegman S; Einsele H; Cavo M; Goldschmidt H; Sonneveld P; Delforge M; Auner HW; Terpos E; Engelhardt M; Caers J; Garderet L; Kortüm KM; O'Dwyer ME; et alii...

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe). in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21
2018
AO Cuneo
AOU Città della Salute di Torino

Fanti S; Ghedini P; Cavo M; Gamberi B; Gay F; Patriarca F; Gallamini A; Bellò M; Bertone E; Rensi M; Bianchi A; Chauvie S; Nanni C; Versari A; Zamagni E;

Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate? in Annals of hematology / Ann Hematol. 2018 Mar;97(3):387-400. doi: 10.1007/s00277-017-3191-7. Epub 2017 Dec 27.
2018
AOU Città della Salute di Torino

Allcott K; Flament A; Gay F; Leleu X; Delforge M;

Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy. in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension / High Blood Press Cardiovasc Prev. 2018 Jun;25(2):209-218. doi: 10.1007/s40292-018-0256-1. Epub 2018
2018
AOU Città della Salute di Torino

Iannaccone A; Bruno G; Ravera A; Gay F; Salvini M; Bringhen S; Sabia L; Avenatti E; Veglio F; Milan A;

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network. in Leukemia / Leukemia. 2018 Jul;32(7):1542-1560. doi: 10.1038/s41375-018-0040-1. Epub 2018 May 2.
2018
AOU Città della Salute di Torino

Beksac M; Waage A; van de Donk NWCJ; Weisel K; Kaiser M; Jackson G; Goldschmidt H; Leleu X; Cook G; Mateos MV; Garderet L; Zweegman S; Terpos E; San-Miguel JF; Dimopoulos MA; Cavo M; Mohty M; Hajek R; Boccadoro M; Avet-Loiseau H; Moreau P; Gay F; Einsele H; Facon T; Delforge M; Ludwig H; Mellqvist UH; Engelhardt M; Caers J; et alii...

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2018 Jul;144(7):1357-1366. doi: 10.1007/s00432-018-2641-5. Epub 2018 Apr 19
2018
AOU Città della Salute di Torino

Corradini P; Tacchetti P; Musto P; Nagler A; Ria R; Caravita T; Benevolo G; Cangialosi C; Marcatti M; Ponticelli E; Baldini L; Rocco S; Rizzi R; Cascavilla N; Angelucci E; Nozzoli C; Oddolo D; Ben-Yehuda D; Guglielmelli T; Mina R; Patriarca F; Crippa C; Spada S; De Paoli L; Di Raimondo F; Cerrato C; Offidani M; Palumbo A; Petrucci MT; et alii...

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives. in Haematologica / Haematologica. 2018 Feb;103(2):197-211. doi: 10.3324/haematol.2017.174573. Epub 2017 Dec 7.
2018
AOU Città della Salute di Torino

Cavo M; Kröger N; Boccadoro M; Dimopoulos M; Einsele H; Ludwig H; Straka C; Hajek R; Garderet L; Zamagni E; Oliva S; van de Donk N; Gramatzki M; Caers J; Auner HW; Giaccone L; Wäsch R; Terpos E; Engelhardt M; Gay F; Goldschmidt H; Bruno B; Sonneveld P;

CD38 as an immunotherapeutic target in multiple myeloma. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2018 Dec;18(12):1209-1221. doi: 10.1080/14712598.2018.1544240. Epub 2018 Nov
2018
AOU Città della Salute di Torino

Bonello F; D'Agostino M; Moscvin M; Cerrato C; Boccadoro M; Gay F; Bonello F; D'Agostino M; Moscvin M; Cerrato C; Boccadoro M; Gay F;

Special problems in the management of elderly patients with multiple myeloma. in European journal of internal medicine / Eur J Intern Med. 2018 Dec;58:64-69. doi: 10.1016/j.ejim.2018.05.027.
2018
AOU Città della Salute di Torino

Gay F; Larocca A; Gay F; Larocca A;

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Dec;132:9-16. doi: 10.1016/j.critrevonc.2018.09.008. Epub 2018 Sep 14.
2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Montefusco V; Palumbo A; Ribolla R; Siniscalchi A; Patriarca F; Pezzatti S; De Sabbata G; Di Renzo N; Rizzi R; Gamberi B; Baldini L; Guglielmelli T; Gilestro M; Catalano L; Marcatti M; Spada S; Petrucci MT; Ria R; Offidani M; De Paoli L; Conticello C; D'Agostino M; Nagler A; Boccadoro M; Gay F; D'Agostino M; De Paoli L; Conticello C; Offidani M; et alii...

Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN). in Leukemia / Leukemia. 2018 Aug;32(8):1697-1712. doi: 10.1038/s41375-018-0142-9. Epub 2018 Apr 25.
2018
AOU Città della Salute di Torino

Einsele H; Boccadoro M; Dimopoulos MA; Offidani M; Gramatzki M; Auner HW; Caers J; Bringhen S; Ludwig H; Straka C; Cavo M; Gay F; Goldschmidt H; Scheubeck S; D'Agostino M; Wäsch R; Terpos E; Zweegman S; Dold SM; Larocca A; Sonneveld P; Engelhardt M; Larocca A; Dold SM; Zweegman S; Terpos E; Wäsch R; D'Agostino M; Scheubeck S; et alii...

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma. in Frontiers in immunology / Front Immunol. 2018 Nov 27;9:2749. doi: 10.3389/fimmu.2018.02749. eCollection 2018.
2018
AOU Città della Salute di Torino

Gay F; Boccadoro M; D'Agostino M; Troia R; Oliva S; Oliva S; Troia R; D'Agostino M; Boccadoro M; Gay F;

Emerging drugs and combinations to treat multiple myeloma. in Oncotarget / Oncotarget. 2017 Jul 15;8(36):60656-60672. doi: 10.18632/oncotarget.19269. eCollection 2017 Sep 1.
2017
AOU Città della Salute di Torino

Larocca A; Mina R; Gay F; Bringhen S; Boccadoro M;

Autologous transplant for myeloma: when the old meets the new. in Oncotarget / Oncotarget. 2017 Oct 8;8(53):90618-90619. doi: 10.18632/oncotarget.21605. eCollection 2017 Oct 31.
2017
AOU Città della Salute di Torino

Gay F; Genuardi M; Boccadoro M;

Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma. in European journal of haematology / Eur J Haematol. 2017 Mar;98(3):289-295. doi: 10.1111/ejh.12834. Epub 2017 Jan 5.
2017
AOU Città della Salute di Torino

Offidani M; Corvatta L; Bringhen S; Gentili S; Troia R; Maracci L; Larocca A; Gay F; Leoni P; Boccadoro M;

2017
AOU Città della Salute di Torino

Gentile M; Magarotto V; Offidani M; Musto P; Bringhen S; Teresa Petrucci M; Gay F; Larocca A; Uccello G; Petrungaro A; Vigna E; Greco R; Grazia Recchia A; Tripepi G; Ria R; Di Raimondo F; Palumbo A; Morabito F;

Novel investigational drugs active as single agents in multiple myeloma. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2017 Jun;26(6):699-711. doi: 10.1080/13543784.2017.1324571. Epub 2017 Ma
2017
AOU Città della Salute di Torino

D'Agostino M; Salvini M; Palumbo A; Larocca A; Gay F;

Multiple myeloma. in Nature reviews. Disease primers / Nat Rev Dis Primers. 2017 Jul 20;3:17046. doi: 10.1038/nrdp.2017.46.
2017
AOU Città della Salute di Torino

Kumar SK; Rajkumar V; Kyle RA; van Duin M; Sonneveld P; Mateos MV; Gay F; Anderson KC;

Plasma cell leukemia: update on biology and therapy. in Leukemia & lymphoma / Leuk Lymphoma. 2017 Jul;58(7):1538-1547. doi: 10.1080/10428194.2016.1250263. Epub 2016 Nov 6.
2017
AOU Città della Salute di Torino

Palumbo A; Gay F; Cerrato C; D'Agostino M; Mina R;

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis. in Oncotarget / Oncotarget. 2017 Jan 24;8(4):5924-5935. doi: 10.18632/oncotarget.12641.
2017
AOU Città della Salute di Torino

Caravita T; Conticello C; Liberati AM; Pescosta N; Petrucci MT; Saraci E; Patriarca F; Genuardi M; Bernardini A; Pautasso C; Passera R; Ferrero S; Drandi D; Gay F; Muccio VE; Gilestro M; Gambella M; Oliva S; Rocci A; Musto P; Boccadoro M; Palumbo A; Omedè P;

2017
AOU Città della Salute di Torino

Ludwig H; Delforge M; Facon T; Einsele H; Gay F; Moreau P; Avet-Loiseau H; Boccadoro M; Hajek R; Mohty M; Cavo M; Dimopoulos MA; San-Miguel JF; Terpos E; Zweegman S; Garderet L; Mateos MV; Cook G; Leleu X; Goldschmidt H; Jackson G; Kaiser M; Weisel K; van de Donk NWCJ; Waage A; Beksac M; Mellqvist UH; Engelhardt M; Caers J; et alii...

Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2017 Aug;17(8):471-478. doi: 10.1016/j.clml.2017.06.014. Epub 2017 Jun 1
2017
AOU Città della Salute di Torino

Gay F; D'Agostino M; Giaccone L; Genuardi M; Festuccia M; Boccadoro M; Bruno B; Gay F; D'Agostino M; Giaccone L; Genuardi M; Festuccia M; Boccadoro M; Bruno B;

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis. in Leukemia / Leukemia. 2017 Aug;31(8):1727-1734. doi: 10.1038/leu.2016.381. Epub 2016 Dec 23.
2017
AOU Città della Salute di Torino

Nagler A; Patriarca F; Caravita T; Falcone AP; Malfitano A; Cafro AM; Liberati AM; Troia R; Omedé P; Offidani M; Carella AM; Salvini M; Ria R; Campbell P; Spada S; Evangelista A; Catalano L; Musto P; Conticello C; Montefusco V; Petrucci MT; Oliva S; Gay F; Spencer A; Hajek R; Palumbo A; Boccadoro M;

Stem Cell Transplantation in Multiple Myeloma. in Current cancer drug targets / Curr Cancer Drug Targets. 2017;17(9):769-781. doi: 10.2174/1568009616666160920090236.
2017
AOU Città della Salute di Torino

Offidani M; Gentili S; Gay F; Aghemo E; Maracci L; Corvatta L; Palumbo A;

Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe). in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):414-21. doi: 10.1007/s00259-015-3200-9. Epub 2015 Oct 16.
2016
AO Cuneo
AOU Città della Salute di Torino

Fanti S; Gamberi B; Cavo M; Gay F; Patriarca F; Gallamini A; Rambaldi I; Rensi M; Bellò M; Bianchi A; Versari A; Chauvie S; Zamagni E; Nanni C;

Nuances in the Management of Older People With Multiple Myeloma. in Current hematologic malignancy reports / Curr Hematol Malig Rep. 2016 Jun;11(3):241-51. doi: 10.1007/s11899-016-0323-4.
2016
AOU Città della Salute di Torino

Pawlyn C; Gay F; Larocca A; Roy V; Ailawadhi S;

Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2015 Oct 20;33(30):3459-66. doi: 10.1200/JCO.2014.60.2466. Epub 2015 Aug 17.
2015
AOU Città della Salute di Torino

Palumbo A; Gay F; Cavallo F; Di Raimondo F; Larocca A; Hardan I; Nagler A; Petrucci MT; Hajek R; Pezzatti S; Delforge M; Patriarca F; Donato F; Cerrato C; Nozzoli C; Yu Z; Boccadifuoco L; Caravita T; Benevolo G; Guglielmelli T; Vincelli D; Jacques C; Dimopoulos MA; Ciccone G; Musto P; Corradini P; Cavo M; Boccadoro M;

Autologous Transplantation in Elderly Multiple Myeloma Patients: Is the Procedure Cost Effective? in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2015 Oct;21(10):1705-6. doi: 10.1016/j.bbmt.2015.08.005. Epub 2015 Aug
2015
AOU Città della Salute di Torino

Gay F; Palumbo A;

2015
AOU Città della Salute di Torino

Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A;

2015
AOU Città della Salute di Torino

Musto P; Simeon V; Grossi A; Gay F; Bringhen S; Larocca A; Guariglia R; Pietrantuono G; Villani O; D'Arena G; Cuomo C; Musto C; Morabito F; Petrucci MT; Offidani M; Zamagni E; Tacchetti P; Conticello C; Milone G; Palumbo A; Cavo M; Boccadoro M;

Autologous transplantation and maintenance therapy in multiple myeloma. in The New England journal of medicine / N Engl J Med. 2014 Sep 4;371(10):895-905. doi: 10.1056/NEJMoa1402888.
2014
AOU Città della Salute di Torino

Palumbo A; Cavallo F; Gay F; Di Raimondo F; Ben Yehuda D; Petrucci MT; Pezzatti S; Caravita T; Cerrato C; Ribakovsky E; Genuardi M; Cafro A; Marcatti M; Catalano L; Offidani M; Carella AM; Zamagni E; Patriarca F; Musto P; Evangelista A; Ciccone G; Omedé P; Crippa C; Corradini P; Nagler A; Boccadoro M; Cavo M;

Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2014 Sep;23(9):1193-209. doi: 10.1517/13543784.2014.920821. Epub 2014 Ju
2014
AOU Città della Salute di Torino

Bringhen S; Gay F; Donato F; Troia R; Mina R; Palumbo A;

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. in Haematologica / Haematologica. 2014 Oct;99(10):1611-7. doi: 10.3324/haematol.2014.103853. Epub 2014 Jul 11.
2014
AOU Città della Salute di Torino

Caltagirone S; Ruggeri M; Aschero S; Gilestro M; Oddolo D; Gay F; Bringhen S; Musolino C; Baldini L; Musto P; Petrucci MT; Gaidano G; Passera R; Bruno B; Palumbo A; Boccadoro M; Omedè P;

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients. in British journal of haematology / Br J Haematol. 2014 Mar;164(6):841-50. doi: 10.1111/bjh.12719. Epub 2014 Jan 23.
2014
AOU Città della Salute di Torino

Rocci A; Gambella M; Aschero S; Baldi I; Trusolino L; Cavallo F; Gay F; Larocca A; Magarotto V; Omedè P; Isaia G; Bertotti A; Liberati AM; Catalano L; De Rosa L; Musto P; Vallone R; Falcone A; Drandi D; Ladetto M; Comoglio PM; Boccadoro M; Palumbo A;

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network. in Haematologica / Haematologica. 2014 Jun;99(6):984-96. doi: 10.3324/haematol.2013.100552. Epub 2014 Mar 21.
2014
AOU Città della Salute di Torino

van de Donk NW; Palumbo A; Johnsen HE; Engelhardt M; Gay F; Gregersen H; Hajek R; Kleber M; Ludwig H; Morgan G; Musto P; Plesner T; Sezer O; Terpos E; Waage A; Zweegman S; Einsele H; Sonneveld P; Lokhorst HM;

Monoclonal antibodies currently in Phase II and III trials for multiple myeloma. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2014 Aug;14(8):1127-44. doi: 10.1517/14712598.2014.908848. Epub 2014 Apr 21.
2014
AOU Città della Salute di Torino

Donato F; Gay F; Bringhen S; Troia R; Palumbo A;

Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report. in Transplant infectious disease : an official journal of the Transplantation Society / Transpl Infect Dis. 2014 Aug;16(4):653-7. doi: 10.1111/tid.12245. Epub 2014 Jun 11.
2014
AOU Città della Salute di Torino

Festuccia M; Giaccone L; Gay F; Brunello L; Maffini E; Ferrando F; Talamo E; Boccadoro M; Serra R; Barbui A; Bruno B;

Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma. in Expert opinion on drug metabolism & toxicology / Expert Opin Drug Metab Toxicol. 2013 Nov;9(11):1517-27. doi: 10.1517/17425255.2013.827169. Epub 2013
2013
AOU Città della Salute di Torino

Gay F; Mina R; Troia R; Bringhen S;

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results. in Blood / Blood. 2013 Aug 22;122(8):1376-83. doi: 10.1182/blood-2013-02-483073. Epub 2013 Jun 17.
2013
AOU Città della Salute di Torino

Gay F; Magarotto V; Crippa C; Pescosta N; Guglielmelli T; Cavallo F; Pezzatti S; Ferrari S; Liberati AM; Oliva S; Patriarca F; Offidani M; Omedé P; Montefusco V; Petrucci MT; Giuliani N; Passera R; Pietrantuono G; Boccadoro M; Corradini P; Palumbo A;